OptiMedica donates photocoagulator to ORBIS

Article

OptiMedica Corp has donated a PASCAL photocoagulator to non-profit organization ORBIS International, under a new partnership between the two companies.

OptiMedica Corp has donated a PASCAL photocoagulator to non-profit organization ORBIS International, under a new partnership between the two organizations.

The PASCAL photocoagulator, which decreases the duration and frequency of photocoagulation while increasing the safety, comfort and efficiency of the procedure, will be used onboard ORBIS's Flying Eye Hospital to train doctors in the developing world to treat retinal disorders, particularly diabetic retinopathy.

The technology was first used by ORBIS on the Flying Eye Hospital's first visit to Laos, a country with 25 ophthalmologists and 30,000 blind among the population of six million. The visit concluded on January 30th and was attended by an engineer from OptiMedica.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.